This next-generation version of EpiCapture utilises machine learning tools that integrate additional patient features, including patient ethnicity...
Akrivia is currently preparing to deploy T-OMICS as a targeted decision-support tool specifically designed to address the unmet needs of the advanced breast cancer patient population...
Approximately 97 per cent of people diagnosed with ALS have TDP-43 pathology, making it a central biological hallmark of the disease...
Health systems are under unprecedented pressure, with rapidly growing data volumes stretching clinical capacity and contributing to care delays...
Singapore’s healthcare system has long been recognised for its strong infrastructure, advanced medical capabilities, and forward-looking policies. In recent years, however, the focus of healthcare development has expanded beyond treatment and hospital care to include a stronger emphasis on preventive healthcare....
Completion of enrollment marks a key milestone toward satisfying FDA post-approval requirements...
This funding from the European Union will support an Egle-led initiative in partnership with a consortium of four leading European scientific institutions to advance the clinical development of EGL-001...
With this recognition, SMO India becomes one of a select group of organisations globally authorised under the FDA’s Third-Party Review Program...
The P-Cure centre is the first and only facility in the world to routinely deliver proton therapy to patients using its upright technology...
CE Mark certification enables commercialisation across Europe and other CE-recognising markets...
